PT3120852T - Agente preventivo e/ou terapêutico para doenças imunitárias - Google Patents
Agente preventivo e/ou terapêutico para doenças imunitáriasInfo
- Publication number
- PT3120852T PT3120852T PT16743556T PT16743556T PT3120852T PT 3120852 T PT3120852 T PT 3120852T PT 16743556 T PT16743556 T PT 16743556T PT 16743556 T PT16743556 T PT 16743556T PT 3120852 T PT3120852 T PT 3120852T
- Authority
- PT
- Portugal
- Prior art keywords
- preventive
- therapeutic agent
- immune diseases
- immune
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Otolaryngology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015017386 | 2015-01-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3120852T true PT3120852T (pt) | 2019-07-16 |
Family
ID=56543555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT16743556T PT3120852T (pt) | 2015-01-30 | 2016-01-29 | Agente preventivo e/ou terapêutico para doenças imunitárias |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9782412B2 (pt) |
| EP (1) | EP3120852B1 (pt) |
| JP (1) | JP6093485B2 (pt) |
| KR (1) | KR101858421B1 (pt) |
| CN (1) | CN107206001B (pt) |
| AU (1) | AU2016213030B2 (pt) |
| BR (1) | BR112017016278B1 (pt) |
| CA (1) | CA2975372C (pt) |
| DK (1) | DK3120852T3 (pt) |
| ES (1) | ES2734364T3 (pt) |
| HU (1) | HUE045532T2 (pt) |
| MX (1) | MX2017009863A (pt) |
| MY (1) | MY197518A (pt) |
| PH (1) | PH12017501336A1 (pt) |
| PL (1) | PL3120852T3 (pt) |
| PT (1) | PT3120852T (pt) |
| RU (1) | RU2705154C2 (pt) |
| SG (1) | SG11201704430SA (pt) |
| TR (1) | TR201910158T4 (pt) |
| TW (1) | TWI638817B (pt) |
| WO (1) | WO2016121953A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3115365T (pt) * | 2015-01-30 | 2018-05-07 | Taiho Pharmaceutical Co Ltd | Novo sal de composto pirimidina fundido e cristal do mesmo |
| JP7304968B2 (ja) * | 2019-12-19 | 2023-07-07 | 大鵬薬品工業株式会社 | 縮合ピリミジン化合物を有効成分とする治療剤 |
| CN112209894B (zh) * | 2020-10-23 | 2023-06-06 | 贵州医科大学 | 5-芳基取代2-氨基苯并恶唑类衍生物、制备方法及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1968979A2 (en) * | 2005-12-08 | 2008-09-17 | Abbott Laboratories | 9-membered heterobicyclic compounds as inhibitors of protein kinases |
| US8987233B2 (en) * | 2006-11-03 | 2015-03-24 | Pharmacyclics, Inc. | Bruton's tyrosine kinase activity probe and method of using |
| WO2009057733A1 (ja) * | 2007-10-31 | 2009-05-07 | Santen Pharmaceutical Co., Ltd. | 血管新生阻害活性を有する新規インドール誘導体 |
| US8338439B2 (en) | 2008-06-27 | 2012-12-25 | Celgene Avilomics Research, Inc. | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
| KR20110025224A (ko) | 2008-06-27 | 2011-03-09 | 아빌라 테라퓨틱스, 인크. | 헤테로아릴 화합물 및 이의 용도 |
| JP2014520863A (ja) * | 2011-07-13 | 2014-08-25 | ファーマサイクリックス，インク． | Ｂｒｕｔｏｎ型チロシンキナーゼの阻害剤 |
| PL2657233T3 (pl) | 2012-01-19 | 2015-01-30 | Taiho Pharmaceutical Co Ltd | 3,5-dipodstawiony związek alkinylobenzenowy i jego sól |
| WO2014036016A1 (en) * | 2012-08-31 | 2014-03-06 | Principia Biopharma Inc. | Benzimidazole derivatives as itk inhibitors |
| NO2947086T3 (pt) * | 2013-08-12 | 2018-06-02 |
-
2016
- 2016-01-29 JP JP2016533731A patent/JP6093485B2/ja active Active
- 2016-01-29 TR TR2019/10158T patent/TR201910158T4/tr unknown
- 2016-01-29 TW TW105102962A patent/TWI638817B/zh active
- 2016-01-29 KR KR1020177018431A patent/KR101858421B1/ko active IP Right Grant
- 2016-01-29 EP EP16743556.9A patent/EP3120852B1/en active Active
- 2016-01-29 CA CA2975372A patent/CA2975372C/en active Active
- 2016-01-29 PL PL16743556T patent/PL3120852T3/pl unknown
- 2016-01-29 CN CN201680007390.2A patent/CN107206001B/zh active Active
- 2016-01-29 ES ES16743556T patent/ES2734364T3/es active Active
- 2016-01-29 AU AU2016213030A patent/AU2016213030B2/en active Active
- 2016-01-29 BR BR112017016278-4A patent/BR112017016278B1/pt active IP Right Grant
- 2016-01-29 SG SG11201704430SA patent/SG11201704430SA/en unknown
- 2016-01-29 MX MX2017009863A patent/MX2017009863A/es unknown
- 2016-01-29 RU RU2017127126A patent/RU2705154C2/ru active
- 2016-01-29 HU HUE16743556A patent/HUE045532T2/hu unknown
- 2016-01-29 PT PT16743556T patent/PT3120852T/pt unknown
- 2016-01-29 WO PCT/JP2016/052732 patent/WO2016121953A1/ja active Application Filing
- 2016-01-29 MY MYPI2017701813A patent/MY197518A/en unknown
- 2016-01-29 DK DK16743556.9T patent/DK3120852T3/da active
- 2016-10-19 US US15/297,196 patent/US9782412B2/en active Active
-
2017
- 2017-07-24 PH PH12017501336A patent/PH12017501336A1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201801024XA (en) | Therapeutic or preventive compositions for il-8-related diseases | |
| IL250990A0 (en) | Materials for human care | |
| PL3120852T3 (pl) | Środek zapobiegawczy i/lub terapeutyczny przeciwko chorobom immunologicznym | |
| IL259383A (en) | A compound for use in the prevention and treatment of neurodegenerative diseases | |
| GB201503139D0 (en) | Diagnostic and therapeutic target | |
| GB201519644D0 (en) | Therapy and pharmaceutical composition | |
| IL257689B (en) | Pharmaceutical preparations and methods for treating diseases related to lack of oxygen | |
| GB201500555D0 (en) | Method and device for the treatment of diseases | |
| GB201521260D0 (en) | Therapeutic and diagnostic target | |
| GB201521264D0 (en) | Therapeutic and diagnostic target | |
| GB201521259D0 (en) | Therapeutic and diagnostic target | |
| GB201521262D0 (en) | Therapeutic and diagnostic target | |
| GB201518306D0 (en) | Therapeutic and diagnostic target | |
| GB201518307D0 (en) | Therapeutic and diagnostic target | |
| GB201518309D0 (en) | Therapeutic and diagnostic target | |
| GB201518310D0 (en) | Therapeutic and diagnostic target | |
| GB201518187D0 (en) | Therapeutic and diagnostic target | |
| GB201518188D0 (en) | Therapeutic and diagnostic target | |
| GB201513114D0 (en) | Therapeutic and diagnostic target | |
| GB201513070D0 (en) | Therapeutic and diagnostic target | |
| GB201513119D0 (en) | Therapeutic and diagnostic target | |
| GB201513004D0 (en) | Therapeutic and diagnostic target | |
| GB201504869D0 (en) | Therapeutic and diagnostic target | |
| GB201504868D0 (en) | Therapeutic and diagnostic target | |
| GB201504863D0 (en) | Therapeutic and diagnostic target |